GlassScriptPhysician profile
Irma E Garcia
NPI 1518573930
$2,937.44
in general payments reported to CMS, 2019-2025
29 companies · $699 in 2025
The $699 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $703 · 2022: $342 · 2023: $496 · 2024: $698 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $532.01 | 2023-2024 | Grafix Pl, Oasis, Collagenase Santyl |
| Abbvie INC. | $357.41 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $280.26 | 2022-2025 | Breztri, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $209.52 | 2024-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Urgo Medical North America, LLC | $172.72 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Lilly USA, LLC | $162.27 | 2021-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $156.72 | 2021-2022 | |
| Philips North America LLC | $136.64 | 2025 | Respiratory |
| Phathom Pharmaceuticals, INC. | $125.75 | 2024 | Voquezna |
| Astellas Pharma US INC | $118.10 | 2021 | |
| Viatris Specialty LLC | $82.42 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $76.56 | 2021-2023 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.37 | 2021-2025 | Ofev, Jascayd |
| Electromed, INC. | $53.36 | 2025 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $53.21 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $50.60 | 2021-2022 | |
| Verona Pharma, INC. | $43.49 | 2025 | Ohtuvayre |
| Dexcom, INC. | $43.03 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $31.27 | 2025 | |
| Baxter Healthcare | $29.46 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.73 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.31 | 2021 | |
| Kci USA, INC. | $20.72 | 2023 | Activ.A.C. |
| Takeda Pharmaceuticals U.S.A., INC. | $17.58 | 2025 | Glassia |
| Merck Sharp & Dohme LLC | $17.37 | 2025 | Keytruda |
| Molnlycke Health Care US, LLC | $16.49 | 2023 | Exufiber Ag+, Mepilex Border Flex, Mepilex Border Post-Op Ag |
| Organogenesis INC. | $15.29 | 2024 | Apligraf |
| Amag Pharmaceuticals, INC. | $13.45 | 2021 | |
| Mylan Specialty L.P. | $13.33 | 2024 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irma Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.